Skip to Content
Merck
  • Involvement of androgen receptor in nitric oxide production induced by icariin in human umbilical vein endothelial cells.

Involvement of androgen receptor in nitric oxide production induced by icariin in human umbilical vein endothelial cells.

FEBS letters (2010-04-27)
Hideki Koizumi, Jing Yu, Ryo Hashimoto, Yasuyoshi Ouchi, Tetsuro Okabe
ABSTRACT

Icariin, a flavonoid isolated from Epimedii herba, stimulated phosphorylation of endothelial nitric oxide synthase (eNOS) at Ser1177, Akt (Ser473) and ERK1/2 (Thr202/Tyr204). The icariin-induced eNOS phosphorylation was abolished by an androgen receptor (AR) antagonist, nilutamide in human umbilical vein endothelial cells (HUVECs). Furthermore, it was also reduced in the cells transfected with small interfering RNA in which the expression of AR was broken down. The icariin-induced eNOS phosphorylation was inhibited by wortmannin, a phosphatidylinositol 3-kinase (PI3K) inhibitor and partially attenuated by PD98059, an upstream inhibitor for ERK1/2. These data suggest that icariin stimulates release of NO by AR-dependent activation of eNOS in HUVECs. PI3K/Akt and MAPK-ERK kinase (MEK)/ERK1/2 pathways were involved in the phosphorylation of eNOS by icariin.

MATERIALS
Product Number
Brand
Product Description

Nilutamide, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
Nilutamide, solid